BAY CITY CAPITAL LLC
SEC CIK 1288452 · EDGAR
BoughtSold
Most active insiders at MDGL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FRIEDMAN PAUL A | Dir | — | $26.66M |
| 2 | Taub Rebecca | Dir | — | $21.68M |
| 3 | Sibold William John | Pres, CEO, Dir | — | $10.48M |
| 4 | BATE KENNETH | Dir | — | $8.03M |
| 5 | Levy Richard S | Dir | — | $7.36M |
| 6 | Dier Mardi | EVP, CFO | — | $3.77M |
| 7 | Huntsman Carole | Chief Commercial Off | — | $1.71M |
| 8 | Soergel David | Chief Medical Off | — | $952.0K |
| 9 | Kelley Shannon T | GC | — | $841.6K |
| 10 | Thakkar Rita | CAO | — | — |
BAY CITY CAPITAL LLC made no open-market trades at MDGL in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-07 | 2021-12-03 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | BAY CITY CAPITAL LLC | 10% | J - Other | $0.00 | -24.2K | 1,261 | -95% | $0 | |
| MI | 2021-12-07 | 2021-12-03 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | BAY CITY CAPITAL LLC | 10% | J - Other | $0.00 | -800.0K | 0 | -100% | $0 |
| DMI | 2021-10-26 | 2021-10-26 | XLO | Xilio Therapeutics, Inc. | BAY CITY CAPITAL LLC | 10% | C - Cnv Deriv | — | +817.0K | 665.7K | New | — |
| DI | 2021-10-26 | 2021-10-26 | XLO | Xilio Therapeutics, Inc. | BAY CITY CAPITAL LLC | 10% | P - Purchase | $16.00 | +312.5K | 1.13M | +38% | +$5.00M |
Purchase Sale Sale after option exercise All abbreviations